Nonpeptide αvβ3 antagonists. Part 11: discovery and preclinical evaluation of potent αvβ3 antagonists for the prevention and treatment of osteoporosis
PJ Coleman, KM Brashear, BC Askew…
Index: Journal of medicinal chemistry, , vol. 47, # 20 p. 4829 - 4837
Full Text: HTML
Citation Number: 75
Abstract
... Journal of Medicinal Chemistry. ... Departments of Medicinal Chemistry, Bone Biology and Osteporosis Research, Drug Metabolism and Pharmacology, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486. J. Med. Chem. ... Chemistry. ...
Related Articles:
[Zhong, Min; Gadek, Thomas R.; Bui, Minna; Shen, Wang; Burnier, John; Barr, Kenneth J.; Hanan, Emily J.; Oslob, Johan D.; Yu, Chul H.; Zhu, Jiang; Arkin, Michelle R.; Evanchik, Marc J.; Flanagan, W. Mike; Hoch, Ute; Hyde, Jennifer; Prabhu, Saileta; Silverman, Jeffrey A.; Wright, Jasmin ACS Medicinal Chemistry Letters, 2012 , vol. 3, # 3 p. 203 - 206]
[Mann, Inderjit S.; Widdowson, David A.; Clough, John M. Tetrahedron, 1991 , vol. 47, # 37 p. 7981 - 7990]
[Zhang, Bang-Le; Wang, Fang-Dao; Yue, Jian-Min Synlett, 2006 , # 4 p. 567 - 570]
[Tetrahedron Letters, , vol. 41, # 31 p. 5803 - 5806]
[Synthetic Communications, , vol. 44, # 9 p. 1307 - 1313]